Some content of this application is unavailable at the moment.
If this situation persists, please contact us atFeedback&Contact
1. (WO1992010182) USE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN THE TREATMENT OF DIABETIC NEPHROPATHY
Latest bibliographic data on file with the International Bureau

Pub. No.: WO/1992/010182 International Application No.: PCT/GB1991/002220
Publication Date: 25.06.1992 International Filing Date: 12.12.1991
Chapter 2 Demand Filed: 28.05.1992
IPC:
A61K 31/41 (2006.01) ,A61K 31/415 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31
Medicinal preparations containing organic active ingredients
33
Heterocyclic compounds
395
having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
41
having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole
415
1,2-Diazoles
Applicants:
SMITHKLINE BEECHAM PLC [GB/GB]; New Horizons Court Brentford Middlesex TW8 9EP, GB (AllExceptUS)
HILL, James [GB/GB]; GB (UsOnly)
Inventors:
HILL, James; GB
Agent:
THOMPSON, Clive, B.; Corporate Patents SmithKline Beecham Mundells, Welwyn Garden City Hertfordshire AL7 1EY, GB
Priority Data:
9017210.514.12.1990GB
Title (EN) USE OF ANGIOTENSIN II RECEPTOR ANTAGONISTS IN THE TREATMENT OF DIABETIC NEPHROPATHY
(FR) UTILISATION D'AGENTS ANTAGONISTES DU RECEPTEUR DE L'ANGIOTENSINE II DANS LE TRAITEMENT DE LA NEPHROPATHIE DIABETIQUE
Abstract:
(EN) The present invention relates to the use of an angiotensin II receptor antagonist in the manufacture of a medicament for the treatment of diabetic nephropathy.
(FR) L'invention se rapporte à l'utilisation d'un agent, antagoniste du récepteur de l'angiotensine II, dans la fabrication d'un médicament destiné à traiter la néphropathie diabétique.
Designated States: AU, CA, JP, KR, US
European Patent Office (AT, BE, CH, DE, DK, ES, FR, GB, GR, IT, LU, MC, NL, SE)
Publication Language: English (EN)
Filing Language: English (EN)
Also published as:
EP0561939JP3512793JPH06503343AU1991090585